Congratulations to Joseph Doyle on his promotion to Professor

Dr Joseph Doyle

Central Clinical School is delighted to announce that infectious disease expert Dr Joseph Doyle has been promoted to Professor.

Prof Doyle is a national and international leader in the field of public health and epidemiology of infectious diseases, with a particular focus on blood borne viruses - viral hepatitis and HIV.

He leads a large, multi-disciplinary research group within the Department of Infectious Diseases that is focused on viral hepatitis and includes postdoctoral fellows, PhD students, research nurses, public health registrars, and other public health practitioners.

He has an impressive record of securing research funding, totalling $36.8M in competitive, philanthropic, public sector and industry income. He has designed, secured funding for, and leads several large clinical trials and cohort studies.

“Professor Doyle is an outstanding clinician-scientist in the Department of Infectious Diseases who is establishing a substantial leadership position nationally and internationally in his field,” said Professor Terence O’Brien, Head of Central Clinical School. “Professor Doyle demonstrates a stellar engagement within and external to the University, as is evidenced by his leadership in government advisory bodies and guidelines development groups, and as an executive of the new Monash University Clinical Trials Centre.”

Prof Doyle has received multiple invitations to speak at major international scientific meetings, including plenary presentations at the Infectious Diseases Society of America, reflecting his international profile in the field. He has been awarded multiple prizes for his team’s research, including the International AIDS Society Prize for HIV Prevention, a Young Tall Poppy Science Award from the Australian Institute of Policy and Science, Club Melbourne Fellow, and the Gust-MacKenzie Medal from the Burnet Institute.

He has advised governments at a state and national level, and also internationally for the World Health Organization and other bodies on public health policy regarding Infectious diseases. He is President-elect of the Austalasian Society for Infectious Diseases; technical advisor to the WHO and TGA; and appointed by government to the Pharmaceutical Benefits Advisory Committee and Communicable Diseases Network of Australia. He also collaborates with industry in particular global hepatitis drug and diagnostic manufacturers who have supported eight investigator-initiated models of care and implementation projects that he has led.

In addition to his role at Central Clinical School, Prof Doyle is also senior specialist infectious diseases physician at Alfred Health and jointly appointed as Deputy Director of Disease Elimination Program and Head of Infectious Diseases Clinical Research at Burnet Institute.